Evaluation of Heart Rate Variability and Endothelial Function Three Months After Bariatric Surgery
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Was performed a longitudinal, study with twenty patients recruited for the bariatric surgery group and 20 for clinical treatment. The analysis of HRV and endothelial function were performed through peripheral arterial tonometry, in patients with obesity before and after three months of bariatric surgery. Were also analyzed GLP-1, insulin and glucose at fast, and 30 and 60 minutes. The results were compared in parallel with a control group with clinical treatment for obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Oct 2015
Typical duration for not_applicable obesity
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 22, 2018
CompletedFirst Submitted
Initial submission to the registry
April 9, 2019
CompletedFirst Posted
Study publicly available on registry
April 11, 2019
CompletedApril 11, 2019
April 1, 2019
5 months
April 9, 2019
April 10, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Rate variability and endothelial function
assessed by peripheral arterial tonometry
3 months
Study Arms (2)
Bariatric Surgery Group
EXPERIMENTALClinical Threatment
OTHERConvencional treatment in a public tertiary outpatients care unit
Interventions
Bariatric Surgery - convencionals Roux-en-Y gastric bypass (RYGB) and vertical gastrectomy (Sleeve; SG)
Eligibility Criteria
You may qualify if:
- Patients with obesity grade 3 \[Body Mass Index (BMI) ≥ 40kg/m2\] or grade 2 (BMI 35-39.9kg/m2) with comorbidities
You may not qualify if:
- Current use of incretin mimetics or inhibitors of dipeptidyl peptidase-4 (DPP4); and history of a previous cardiovascular event (acute myocardial infarction, stroke or peripheral obstructive arterial disease)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rio de Janeiro State Universitylead
- Eliete Bouskelacollaborator
Related Publications (1)
Gomide Braga T, das Gracas Coelho de Souza M, Maranhao PA, Menezes M, Dellatorre-Teixeira L, Bouskela E, Le Roux CW, Kraemer-Aguiar LG. Evaluation of Heart Rate Variability and Endothelial Function 3 Months After Bariatric Surgery. Obes Surg. 2020 Jun;30(6):2450-2453. doi: 10.1007/s11695-020-04397-4.
PMID: 31916132DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
April 9, 2019
First Posted
April 11, 2019
Study Start
October 1, 2015
Primary Completion
February 25, 2016
Study Completion
February 22, 2018
Last Updated
April 11, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share